semaglutide salts Compounded Some Pharmacies Are Offering Unauthorized

About Wegovy HD (semaglutide) injection 7.2 mg The FDA approval of Wegovy HD is based on the results of the STEP UP program, which included the phase 3 STEP UP clinical trial, which was a 72-week randomized, double-blinded, placebo-controlled and active-controlled superiority trial designed to evaluate the efficacy and safety of once-weekly semaglutide injection 7.2 mg compared to semaglutide injection 2.4 mg and placebo as an adjunct to lifestyle intervention.1,2 1,407 adults with BMI 30 kg/m2 without diabetes were included in the trial

Safety history: pancreatitis, gallbladder disease, or severe gut symptoms

Some individuals may experience mild digestive discomfort when starting supplementation, which typically resolves with continued use or dose adjustment

Blood Cells Mol Dis